<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>UNITED
STATES</B></FONT><FONT STYLE="font-size: 10pt"> </FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<B>April 2, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ALBANY MOLECULAR RESEARCH, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-weight: bold; text-align: center">Delaware</TD>
    <TD STYLE="width: 34%; font-weight: bold; text-align: center">000-25323</TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center">14-1742717</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(State or other jurisdiction</TD>
    <TD STYLE="text-align: center">(Commission</TD>
    <TD STYLE="text-align: center">(IRS Employer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">of incorporation)</TD>
    <TD STYLE="text-align: center">File Number)</TD>
    <TD STYLE="text-align: center">Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-weight: bold; text-align: center">21 Corporate Circle, P.O. Box 15098, Albany, NY</TD>
    <TD STYLE="width: 50%; font-weight: bold; text-align: center">12212</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(Address of principal executive offices)</TD>
    <TD STYLE="text-align: center">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>(518) 512-2000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;(Former name or former address, if
changed since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
( <I>see</I> General Instruction A.2. below) :</P>

<P STYLE="font: 10pt Wingdings; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Wingdings; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Wingdings; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Wingdings; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 5.02(b)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 2, 2012, Dr. Paul Anderson informed the Company that
he will not stand for reelection at the upcoming annual meeting of shareholders of the Company. Dr. Anderson&rsquo;s decision was
not the result of any disagreement with the Company on any matter relating to the Company&rsquo;s operations, policies or practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 5.02(e)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 5, 2012 the Company entered into an Amended and Restated
Employment Agreement (each an &ldquo;<U>Amended Agreement</U>&rdquo;, and collectively, the &ldquo;<U>Amended Agreements</U>&rdquo;)
with each of Dr. Thomas D&rsquo;Ambra, Mr. Mark Frost, Dr. Bruce Sargent, Dr. Steve Hagen and Ms. Lori Henderson (each an &ldquo;<U>Executive</U>&rdquo;,
and collectively, the &ldquo;<U>Executives</U>&rdquo;). The Amended Agreements, among other things, provide the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>For Dr. D&rsquo;Ambra and Mr. Frost, the Amended Agreements replaced the existing &lsquo;gross up&rsquo; language with a &lsquo;modified
cut back&rsquo; provision, which provision would apply to reduce the Severance Payments (as defined herein)&nbsp;to the Threshold
Amount (as defined herein)&nbsp;only if the Executive is better off on an after-tax&nbsp;basis&nbsp;with the reduction in Severance
Payments. This modification reflects the consideration by the Compensation Committee of the Board of Directors of the changing
institutional investor views with respect to &ldquo;gross up&rdquo; provisions in executive employment agreements by making these
provisions less favorable to the Executive and potentially less costly to the Company in the event of a Change of Control. The
term &ldquo;Severance Payments&rdquo; means the aggregate amount of any compensation, payment or distribution by the Company to
or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement
or otherwise calculated in a manner consistent with Section 280G of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;)
and the applicable regulations thereunder. The term &ldquo;Threshold Amount&rdquo; means an amount equal to three (3) times the
Executive&rsquo;s &ldquo;base amount&rdquo; within the meaning of Section 280G(b)(3) of the Code and the regulations promulgated
thereunder less one dollar ($1.00). For Ms. Henderson, Dr.Sargent and Dr. Hagen, the Amended Agreements replaced the existing full
cut back provision with the modified cut back provision described in the foregoing sentences.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>For each Executive, the definition of Change of Control was revised to require that the event causing the Change of Control
be consummated or closed in order for such event to be considered a Change of Control. The amended definition of Change of Control
is consistent with the definition of such action which is currently included in the Company&rsquo;s Amended 2008 Option and Incentive
Plan and is more restrictive than the previous definition, thereby limiting the situations in which a Change of Control might be
deemed to have occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>For each Executive, other than Dr. D&rsquo;Ambra, the Amended Agreements increased the severance that would be payable to the
Executive in the event that he or she was terminated within two years following a Change of Control of the Company such that the
Executive would receive 1.5 times the sum of (x) the Executive&rsquo;s base salary at the rate then in effect plus (y) an amount
equal to the Executive&rsquo;s cash bonus, if any, received in respect of the immediately preceding year within thirty (30) days
of the date of termination. Prior to the modification described herein, each Executive&rsquo;s employment agreement, other than
Dr. D&rsquo;Ambra&rsquo;s, provided that in the event that he or she was terminated within two years following a Change of Control
of the Company the Executive would receive 1 times the sum of (x) the Executive&rsquo;s base salary at the rate then in effect
plus (y) an amount equal to the Executive&rsquo;s cash bonus, if any, received in respect of the immediately preceding year within
thirty (30) days of the date of termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>For each Executive, the Amended Agreements require that within thirty (30) days of a Change of Control, the Company shall pay
to the Executive a lump sum equal to the Executive&rsquo;s pro rata target cash bonus for the year in which the Change of Control
occurred (as such may be set forth in the Company&rsquo;s bonus plan for such year and calculated assuming target achievement of
corporate and personal goals); such pro rata amount to be determined based on the actual date of the closing of such Change in
Control transaction. This provision was not in the employment agreements prior to the modification described herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing summary of the Amended Agreements does not purport
to be complete and is qualified in its entirety by reference to the full texts of the Amended Agreements, copies of which are filed
as Exhibits 10.1 through 10.5 attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;9.01 Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD>Exhibits</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.1</TD><TD>Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Thomas E. D&rsquo;Ambra,
Ph.D.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.2</TD><TD>Amended and Restated Employment Agreement, dated as of April 5 2012, by and between the Company and Mark T. Frost.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.3</TD><TD>Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Steven R. Hagen, Ph.D.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.4</TD><TD>Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Bruce J. Sargent, Ph.D.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.5</TD><TD>Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Lori M. Henderson.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>Date: April 5, 2012</TD>
    <TD COLSPAN="2">ALBANY MOLECULAR RESEARCH, INC.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 59%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: black 1pt solid">/s/ Mark T. Frost</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Mark T. Frost</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">Title: Senior Vice President, Administration,</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">Chief Financial Officer and Treasurer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 10%; vertical-align: top; border-bottom: windowtext 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No.</P></TD>
    <TD STYLE="width: 1%; vertical-align: top; text-indent: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 89%; vertical-align: bottom; border-bottom: windowtext 1pt solid; text-indent: 0.5in">Description</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>10.1</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Thomas E. D&rsquo;Ambra, Ph.D.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>10.2</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Mark T. Frost.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>10.3</TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amended and Restated Employment Agreement, dated as of April
        5, 2012, by and between the Company and Steven R. Hagen, Ph.D.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.6pt">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>10.4</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Bruce J. Sargent, Ph.D.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>10.5</TD>
    <TD STYLE="text-indent: 0.6pt">&nbsp;</TD>
    <TD STYLE="text-indent: 0.6pt">Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Lori M. Henderson.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v308645_8k.htm", "description": "CURRENT REPORT", "secsgml_size_bytes": 24401}]
{"company-data": {"conformed-name": "ALBANY MOLECULAR RESEARCH INC", "cik": "0001065087", "assigned-sic": "8731", "irs-number": "141742717", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-25323", "film-number": "12745964"}, "business-address": {"street1": "21 CORPORATE CIRCLE", "street2": "P O BOX 15098", "city": "ALBANY", "state": "NY", "zip": "12203-5154", "phone": "5184640279"}, "mail-address": {"street1": "21 CORPORATE CIRCLE", "street2": "P O BOX 15098", "city": "ALBANY", "state": "NY", "zip": "12203-5154"}}
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 2, 2012
ALBANY MOLECULAR RESEARCH, INC.
(Exact Name of Registrant as Specified in
Charter)
Delaware
000-25323
14-1742717
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
21 Corporate Circle, P.O. Box 15098, Albany, NY
12212
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including
area code:
(518) 512-2000
(Former name or former address, if
changed since last report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(
see
General Instruction A.2. below) :
¨
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Item 5.02(b)
On April 2, 2012, Dr. Paul Anderson informed the Company that
he will not stand for reelection at the upcoming annual meeting of shareholders of the Company. Dr. Anderson's decision was
not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Item 5.02(e)
On April 5, 2012 the Company entered into an Amended and Restated
Employment Agreement (each an "
Amended Agreement
", and collectively, the "
Amended Agreements
")
with each of Dr. Thomas D'Ambra, Mr. Mark Frost, Dr. Bruce Sargent, Dr. Steve Hagen and Ms. Lori Henderson (each an "
Executive
",
and collectively, the "
Executives
"). The Amended Agreements, among other things, provide the following:
·
For Dr. D'Ambra and Mr. Frost, the Amended Agreements replaced the existing 'gross up' language with a 'modified
cut back' provision, which provision would apply to reduce the Severance Payments (as defined herein) to the Threshold
Amount (as defined herein) only if the Executive is better off on an after-tax basis with the reduction in Severance
Payments. This modification reflects the consideration by the Compensation Committee of the Board of Directors of the changing
institutional investor views with respect to "gross up" provisions in executive employment agreements by making these
provisions less favorable to the Executive and potentially less costly to the Company in the event of a Change of Control. The
term "Severance Payments" means the aggregate amount of any compensation, payment or distribution by the Company to
or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement
or otherwise calculated in a manner consistent with Section 280G of the Internal Revenue Code of 1986, as amended (the "
Code
")
and the applicable regulations thereunder. The term "Threshold Amount" means an amount equal to three (3) times the
Executive's "base amount" within the meaning of Section 280G(b)(3) of the Code and the regulations promulgated
thereunder less one dollar ($1.00). For Ms. Henderson, Dr.Sargent and Dr. Hagen, the Amended Agreements replaced the existing full
cut back provision with the modified cut back provision described in the foregoing sentences.
·
For each Executive, the definition of Change of Control was revised to require that the event causing the Change of Control
be consummated or closed in order for such event to be considered a Change of Control. The amended definition of Change of Control
is consistent with the definition of such action which is currently included in the Company's Amended 2008 Option and Incentive
Plan and is more restrictive than the previous definition, thereby limiting the situations in which a Change of Control might be
deemed to have occurred.
·
For each Executive, other than Dr. D'Ambra, the Amended Agreements increased the severance that would be payable to the
Executive in the event that he or she was terminated within two years following a Change of Control of the Company such that the
Executive would receive 1.5 times the sum of (x) the Executive's base salary at the rate then in effect plus (y) an amount
equal to the Executive's cash bonus, if any, received in respect of the immediately preceding year within thirty (30) days
of the date of termination. Prior to the modification described herein, each Executive's employment agreement, other than
Dr. D'Ambra's, provided that in the event that he or she was terminated within two years following a Change of Control
of the Company the Executive would receive 1 times the sum of (x) the Executive's base salary at the rate then in effect
plus (y) an amount equal to the Executive's cash bonus, if any, received in respect of the immediately preceding year within
thirty (30) days of the date of termination.
·
For each Executive, the Amended Agreements require that within thirty (30) days of a Change of Control, the Company shall pay
to the Executive a lump sum equal to the Executive's pro rata target cash bonus for the year in which the Change of Control
occurred (as such may be set forth in the Company's bonus plan for such year and calculated assuming target achievement of
corporate and personal goals); such pro rata amount to be determined based on the actual date of the closing of such Change in
Control transaction. This provision was not in the employment agreements prior to the modification described herein.
The foregoing summary of the Amended Agreements does not purport
to be complete and is qualified in its entirety by reference to the full texts of the Amended Agreements, copies of which are filed
as Exhibits 10.1 through 10.5 attached hereto.
Item 9.01 Financial Statements and Exhibits
(d)
Exhibits
10.1
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Thomas E. D'Ambra,
Ph.D.
10.2
Amended and Restated Employment Agreement, dated as of April 5 2012, by and between the Company and Mark T. Frost.
10.3
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Steven R. Hagen, Ph.D.
10.4
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Bruce J. Sargent, Ph.D.
10.5
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Lori M. Henderson.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 5, 2012
ALBANY MOLECULAR RESEARCH, INC.
By:
/s/ Mark T. Frost
Name: Mark T. Frost
Title: Senior Vice President, Administration,
Chief Financial Officer and Treasurer
EXHIBIT INDEX
Exhibit
No.
Description
10.1
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Thomas E. D'Ambra, Ph.D.
10.2
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Mark T. Frost.
10.3
Amended and Restated Employment Agreement, dated as of April
        5, 2012, by and between the Company and Steven R. Hagen, Ph.D.
10.4
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Bruce J. Sargent, Ph.D.
10.5
Amended and Restated Employment Agreement, dated as of April 5, 2012, by and between the Company and Lori M. Henderson.